Byotrol (BYOT)

Sector:

Industrial Chemicals

Index:

FTSE AIM All-Share

 0.13p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.25
  • 52 Week Low: 0.075
  • Currency: UK Pounds
  • Shares Issued: 453.89m
  • Volume: 2,214,181
  • Market Cap: £0.57m
  • RiskGrade: 212

EPA approves Byotrol sanitiser in the US

By Josh White

Date: Tuesday 13 Jun 2017

LONDON (ShareCast) - (ShareCast News) - Specialist anti-microbial technology company Byotrol announced on Tuesday that the US EPA had formally approved Byotrol's proprietary 24-hour germ-kill surface sanitiser for sale in the US.
The AIM-traded firm said the formulation had been under development at Byotrol for over seven years, and the directors believed it offered "unique performance characteristics" to US consumers and businesses.

To those consumers, Byotrol said its products would be able to "claim high performance cleaning" and virucidal action, plus long-lasting benefits such as 24-hour surface protection against bacteria, a product scientifically proven to kill more than 99.9% of bacteria for 24 hours, seven day mold and mildew prevention, and the elimination of over 99.9% of viruses.

The directors said they were not aware of any other cleaning or sanitizing products that could make such claims for US consumers, and as such they believed the approval gave Byotrol a "unique opportunity" in the "substantial" US market.

To US businesses, Byotrol said the formulation would be positioned to offer cost-benefits, such as higher infection control for less chemical use and decreased absenteeism from work.

The EPA had specifically approved the product's use - and the 24-hour claim - in domestic households, travel and leisure, janitorial and sanitation environments, pet and vet environments and all non-food contact surfaces.

It said the product had also been approved for use as a surface sanitiser in hospital environments.

Byotrol said it had been exploring alliances and commercial opportunities with various US organisations since the application was made to the EPA, with Tuesday's approval set to accelerate those discussions.

"We are very excited to gain this registration," said chief executive David Traynor.

"This project is one of 3 core R&D initiatives in the Company, so its successful conclusion is a very significant moment for us.

"We are not aware of any product in the US market that can make competing 24-hour germ-kill claims, yet we are very confident that such claims are valued by both consumers and business users in markets that we estimate in retail alone total over $1bn."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Byotrol Market Data

Currency UK Pounds
Share Price 0.13p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.25
52 Week Low 0.075
Volume 2,214,181
Shares Issued 453.89m
Market Cap £0.57m
RiskGrade 212

Byotrol Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
98.39% below the market average98.39% below the market average98.39% below the market average98.39% below the market average98.39% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Income Not Available
Growth
37.3% below the market average37.3% below the market average37.3% below the market average37.3% below the market average37.3% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Byotrol Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:28 15,000 @ 0.082p
16:06 13,000 @ 0.082p
15:08 75,268 @ 0.13p
14:59 6,778 @ 0.082p
14:45 40,816 @ 0.082p

Byotrol Key Personnel

CFO Chris Sedwell

Top of Page